Skip to Content

WPI 3620 (Armodafinil 50 mg)

Pill imprint WPI 3620 has been identified as Armodafinil 50 mg.

Armodafinil is used in the treatment of obstructive sleep apnea/hypopnea syndrome; narcolepsy; shift work sleep disorder; chronic fatigue syndrome; adhd (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Armodafinil 50 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Armodafinil
Imprint:
WPI 3620
Strength:
50 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Watson Laboratories, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide